More than 6 million Americans currently live with Alzheimer's disease, a number predicted to rise as our population ages.

This National Alzheimer's Month, learn about the new blood test that could help identify your risk and the simple lifestyle ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

Participants who chose not to learn their results said it would place a burden on themselves and their family members. As ...

The July 16 event includes sessions on distinguishing dementia from normal aging and innovative approaches like ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Researchers at Cardiff University created the first stem cell platform based on Alzheimer’s polygenic risk scores. Using ...

The Alzheimer's Association estimates over 7.2 million Americans aged 65 and older will live with Alzheimer's by 2025, with ...

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10 percent of people over the age of 65 and one third of people aged 85 and above. Besides environmental ...

After witnessing my mum's cognitive decline and with dementia now the leading cause of death for Australian women, I can't ...